A client is placed on a medical regimen of doxorubicin (Adriamycin), cyclophosphamide, and fluorouracil for breast cancer. Which side effect seen in the client would the nurse report to the primary health care provider immediately?

Rationale: A. Nausea and vomiting are expected side effects of chemotherapy due to stimulation of the chemoreceptor trigger zone and gastrointestinal irritation. These symptoms should be managed with antiemetic therapy but do not require urgent provider notification unless they become severe and unmanageable. B. Shortness of breath is an abnormal and potentially life-threatening finding that must be reported immediately. The chemotherapeutic agent doxorubicin (Adriamycin) is known for its cardiotoxic effects, which can lead to cardiomyopathy, heart failure, or pulmonary edema. Early symptoms include dyspnea, cough, fatigue, and peripheral edema. Prompt recognition and intervention are critical to prevent irreversible cardiac damage. C. Mucositis (inflammation of the mouth and mucous membranes) is a common, nonemergent side effect of fluorouracil. It should be managed with oral hygiene, topical treatments, and pain control, but it does not require immediate reporting unless severe or accompanied by infection. D. Hair loss (alopecia) is an expected and reversible side effect of many chemotherapy drugs, including doxorubicin and cyclophosphamide. While distressing, it is not a medical emergency.